Research Advisory Committee

Dr Lisa A. Selbie, Ph.D. Chair
Dr. Selbie received her Ph.D. in Biochemistry, Molecular Biology and Cell Biology at Northwestern University and began her career as both a scientist and project leader at the Garvan Institute of Medical Research in Sydney, Australia studying the cloning and expression of neuropeptide receptor genes. Dr Selbie moved to England in 1994 where she worked at Queens Medical School at the University of Nottingham as a Wellcome Trust Research Fellow for four years, studying cell-based models of receptor signal transduction. Dr. Selbie then moved to the US and for the past 11 years, has developed and delivered on-ground and online courses as a lecturer for Johns Hopkins University’s Advanced Biotechnology Studies Program MS/MBA Program. After returning to Sydney in 2003, Dr Selbie has also been a consultant with an Australian management consultancy in the biotechnology and healthcare sectors, an instructor with Biotech Primer Inc., a global company providing biotechnology training for the non-scientist. Dr Selbie has served as a member of the NSW AusBiotech Committee and is a Non Executive Director of HeartKids Australia in addition to her role as Chair of the Research Advisory Committee.

Dr Anne Fletcher –  BSc, MSc, PhD, FAICD, FAIMS
Anne Fletcher is a non-executive director, currently serving on the Chinese Medicine Board of Australia and the Therapeutic Goods Administration (TGA) Advisory Committee for Biologicals. Anne was previously on the boards of the Australian Red Cross Blood Service, the Australian Bone Marrow Donor Registry, the CRC for Vaccine Technology and HeartKids Australia. In her early career Anne worked in diagnostic laboratories. After undertaking postgraduate study she pursued a career in medical research at the University of Sydney and the Australian Red Cross Blood Service. Anne managed the Australian research program of the newly formed national blood service. In 2002 Anne established a health consultancy which provided advice to the biotechnology, health and medical research sectors. Anne has been instrumental in establishing several research funding schemes, including a research fund for the Australian and New Zealand Society of Blood Transfusion. Anne served on the inaugural Consultative Council for the Victorian Cancer Agency, a Victorian government-funded initiative to provide translational research funding to Victorian cancer research and health services. Anne joined the HeartKids Australia board in August 2010 and established the Research Advisory Committee which she chaired until June 30 2014.

Dr Tom Gentles – Independent Advisor MBChB (Auckland), MD, FRACP
Tom Gentles was awarded a senior fellowship from the Heart Foundation of New Zealand in 1994 whilst working as a fellow in cardiology at The Children’s Hospital in Boston, and Harvard Medical School.
He took up a position as senior Heart Foundation Fellow at Green Lane Hospital for three years. This tenure included research into heart muscle function. Following this he was appointed a Consultant Paediatric Cardiologist at Green Lane Hospital and is currently Director of the Paediatric and Congenital Cardiac Service at Starship Children’s Hospital in Auckland New Zealand. Dr Gentles has maintained an active research role and continues to publish in a number of peer reviewed journals and is involved in multi-centre studies in New Zealand and Australian centres. He is an invited speaker at national and international meetings and is a New Zealand representative of the Australian and New Zealand Paediatric Cardiac Association. He is a fellow of the Cardiac Society of Australia and New Zealand and is the Chair of the Paediatric and Congenital Council of the Cardiac Society.

Dr Jemma Lawson, Ph.D.
Dr Lawson achieved her Ph.D. in Molecular Biology and Cell Biology at Flinders University of South Australia, in collaboration with the Co-operative Research Centre for Tissue Growth and Repair. Dr. Lawson subsequently began her career in the biotechnology industry at GroPep Ltd, undertaking roles in research: investigating signal transduction pathways in mammalian cell culture, project management: as the team lead for commercial production of growth factors and receptors for scientific research, and scientific evaluation: seeking and assessing in-licensing opportunities for early phase clinical development. In 2006 Dr Lawson embarked on her current career path in Clinical Research, initially working for a small Australian Clinical Research Organisation (CRO), operating in a dual role as a Clinical Research Associate and a Clinical Project Manager. She currently works for a large Global CRO as the Clinical Team Leader, responsible for clinical operations across South Australia and Western Australia. In addition to resource management and personnel management, Dr Lawson continues to keep up to date with Australian clinical research Regulatory and Ethical requirements by continuing to work also as a Senior Clinical Research Associate on a selection of clinical trials across a broad range of therapeutic areas.

Jemma’s journey with HeartKids commenced in 2009 when her 1 year old son was diagnosed with an Atrial Septal Defect (ASD), following investigation of a heart murmur. The ASD was successfully closed via a cardiac catheter procedure at the Royal Children’s Hospital in Melbourne, in 2013.

Dr. Graham Nunn


South Australia